Skip to main content
. 2022 Mar 18;27(5):340–e374. doi: 10.1093/oncolo/oyab062

Figure 3.

Figure 3.

Kaplan-Meier curves of progression-free survival (PFS) (A) and overall survival (B) by HER2 status. (A) The median PFS for the IHC 3+ and IHC 2+/FISH-positive subgroups were 2.2 (95% CI, 0.0-5.6) and 2.4 (95% CI, 0.0-5.0) months, respectively (P = .993). (B) The median OS for these subgroups were 8.8 (95% CI, 5.9-11.7) and 10.8 (95% CI, 8.4-13.2) months, respectively (P = .670). IHC, immunocytochemistry; FISH, fluorescence in situ hybridization.